KRT19 and lung carcinoma: Moreover, KRT19 transcription was reported to be augmented by activation of the HER2/ERK/SP1 signaling pathway, resulting in translocation of KRT19 to the HER2 receptor; consequently, HER2 activation was stabilized in breast and lung cancers [15,16].